Search Results
SABCS 2013: Triple-Negative Therapy and Chemotherapy
SABCS 2013: Local Therapy for Breast Cancer
SABCS 2013: Therapy for HER2+ Breast Cancer
Triple Negative Breast Cancer: What you need to know
SABCS 2013: Neoadjuvant Focus
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer
Triple-negative breast cancer: Adding carboplatin to presurgery chemotherapy improved survival
SABCS 2013: NeoALTTO, breast cancer with pathologic complete response, event-free & overall survival
SABCS 2013: Hormone Positive Therapy
Targeting Advanced Triple-Negative Breast Cancer | Dana-Farber Cancer Institute
Triple Negative Breast Cancer - O'Regan
Neoadjuvant and adjuvant therapy in triple negative breast cancer
